| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |